1. Home
  2. CYTH vs MXC Comparison

CYTH vs MXC Comparison

Compare CYTH & MXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYTH
  • MXC
  • Stock Information
  • Founded
  • CYTH 1990
  • MXC 1972
  • Country
  • CYTH United States
  • MXC United States
  • Employees
  • CYTH N/A
  • MXC N/A
  • Industry
  • CYTH Biotechnology: Pharmaceutical Preparations
  • MXC Oil & Gas Production
  • Sector
  • CYTH Health Care
  • MXC Energy
  • Exchange
  • CYTH Nasdaq
  • MXC Nasdaq
  • Market Cap
  • CYTH 20.4M
  • MXC 24.0M
  • IPO Year
  • CYTH N/A
  • MXC N/A
  • Fundamental
  • Price
  • CYTH $0.69
  • MXC $12.12
  • Analyst Decision
  • CYTH Buy
  • MXC
  • Analyst Count
  • CYTH 3
  • MXC 0
  • Target Price
  • CYTH $0.95
  • MXC N/A
  • AVG Volume (30 Days)
  • CYTH 21.2K
  • MXC 9.3K
  • Earning Date
  • CYTH 11-14-2024
  • MXC 11-07-2024
  • Dividend Yield
  • CYTH N/A
  • MXC 0.82%
  • EPS Growth
  • CYTH N/A
  • MXC N/A
  • EPS
  • CYTH N/A
  • MXC 0.57
  • Revenue
  • CYTH $870,725.00
  • MXC $6,926,917.00
  • Revenue This Year
  • CYTH N/A
  • MXC N/A
  • Revenue Next Year
  • CYTH $24.49
  • MXC N/A
  • P/E Ratio
  • CYTH N/A
  • MXC $21.44
  • Revenue Growth
  • CYTH N/A
  • MXC N/A
  • 52 Week Low
  • CYTH $0.59
  • MXC $9.02
  • 52 Week High
  • CYTH $2.12
  • MXC $16.52
  • Technical
  • Relative Strength Index (RSI)
  • CYTH 47.10
  • MXC 48.96
  • Support Level
  • CYTH $0.61
  • MXC $11.75
  • Resistance Level
  • CYTH $0.77
  • MXC $13.36
  • Average True Range (ATR)
  • CYTH 0.05
  • MXC 0.55
  • MACD
  • CYTH -0.00
  • MXC 0.02
  • Stochastic Oscillator
  • CYTH 55.63
  • MXC 31.89

About CYTH Cyclo Therapeutics Inc.

Cyclo Therapeutics Inc is a clinical-stage biotechnology firm. The company is engaged in developing cyclodextrin-based products for treating neurodegenerative diseases, particularly Niemann-Pick Type C disease (NPC). The company's lead drug candidate, Trappsol Cyclo, has undergone clinical trials for NPC treatment. Operating in one segment, the company focuses on developing and commercializing cyclodextrin-based treatments for rare diseases. Revenue primarily comes from selling cyclodextrins and related products to pharmaceutical and nutritional industries, with Trappsol HPB and Trappsol Fine Chemical being significant contributors.

About MXC Mexco Energy Corporation

Mexco Energy Corporation is an independent oil and gas company. It is engaged in the exploration, development, and production of natural gas and crude oil properties located in the United States. The company carried out its operation in the Permian Basin of West Texas. It is focusing on two primary areas, the Delaware Basin located in the Western portion of the Permian Basin including Lea and Eddy Counties, New Mexico and Loving County, Texas, and the Midland Basin located in the Eastern portion of the Permian Basin including Reagan, Upton, Midland, Martin, Howard, and Glasscock Counties, Texas. The company generates revenue from Oil sales, Natural gas sales, oil and gas royalty interests.

Share on Social Networks: